Using existing technology, researchers are hopeful that a simple blood test that can detect fetal DNA in expectant mothers will be able to diagnose Down’s syndrome as early as 8 weeks after conception. Unlike invasive procedures such as amniocentesis and chorionic villus sampling (CVS), the test poses no risk to the fetus.
0 comments:
Post a Comment